HKD 48.0
(7.5%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 418.7 Million CNY | 243.29% |
2022 | 121.96 Million CNY | 210.65% |
2021 | 39.26 Million CNY | -41.28% |
2020 | 66.86 Million CNY | -12.54% |
2019 | 76.44 Million CNY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 719.54 Million CNY | 4.42% |
2024 Q1 | 719.54 Million CNY | 71.85% |
2023 Q3 | 458.49 Million CNY | 38.35% |
2023 FY | 418.7 Million CNY | 243.29% |
2023 Q2 | 331.4 Million CNY | 5.75% |
2023 Q4 | 418.7 Million CNY | -8.68% |
2023 Q1 | 313.37 Million CNY | 156.93% |
2022 Q2 | 150.52 Million CNY | 9.06% |
2022 Q1 | 138.02 Million CNY | 251.55% |
2022 FY | 121.96 Million CNY | 210.65% |
2022 Q4 | 121.96 Million CNY | 9.77% |
2022 Q3 | 111.11 Million CNY | -26.18% |
2021 FY | 39.26 Million CNY | -41.28% |
2021 Q4 | 39.26 Million CNY | 42.57% |
2021 Q3 | 27.53 Million CNY | -5.4% |
2021 Q2 | 29.1 Million CNY | -99.48% |
2021 Q1 | 5.6 Billion CNY | 8284.88% |
2020 FY | 66.86 Million CNY | -12.54% |
2020 Q4 | 66.86 Million CNY | -95.38% |
2020 Q3 | 1.44 Billion CNY | 0.0% |
2020 Q1 | - CNY | 0.0% |
2019 FY | 76.44 Million CNY | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | 52.86 Million HKD | -692.004% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 92.94% |